Adrian Haigh

Directeur/Membre du Conseil chez PTC Therapeutics Ltd.

Profil

Adrian James Haigh currently works at PTC Therapeutics Ltd., as Director from 2014.
Mr. Haigh also formerly worked at Arch Biopartners, Inc., as Independent Director from 2014 to 2021, Amgen, Inc., as General Manager-Portugal & Scandinavia from 2002 to 2007, Schering-Plough Corp., as Principal, PTC Therapeutics, Inc., as Senior Vice President & Head-International, Gentium Srl, as Senior Vice President-Commercial Operations, EUSA Pharma, Inc., as Executive VP-Global Marketing & Corporate Planning, GSK Plc, as Principal, Organon NV, as Principal, Novo Nordisk, Inc., as Principal, Biogen Canada, Inc., as Regional Vice President-Commercial Operations, Biogen International GmbH, as Regional Vice President-Commercial Operations, Gentium GmbH, as COO & Senior Vice President-Commercial Operations, and Fennec Pharmaceuticals, Inc., as Chief Operating Officer from 2023 to 2024.
Mr. Haigh received his undergraduate degree from the University of Huddersfield.

Postes actifs de Adrian Haigh

Sociétés	Poste	Début
PTC Therapeutics Ltd.	Directeur/Membre du Conseil	09/11/2014

Anciens postes connus de Adrian Haigh

Sociétés	Poste	Fin
FENNEC PHARMACEUTICALS INC.	Directeur des opérations	30/06/2024
PTC THERAPEUTICS, INC.	Corporate Officer/Principal	31/12/2022
ARCH BIOPARTNERS INC.	Directeur/Membre du Conseil	10/06/2021
AMGEN INC.	Corporate Officer/Principal	01/01/2007
Biogen Canada, Inc.	Corporate Officer/Principal	-